Aarkstore Enterprise Obesity - Pipeline Review, Q4 2010

Aarkstore announce a new report "Obesity - Pipeline Review

, Q4 2010" through its vast collection of market research report.

Obesity Pipeline Review, Q4 2010, provides an overview of the Obesity therapeutic pipeline. This report provides information on the therapeutic development for Obesity, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Obesity. Obesity-Pipeline Review 2010, Q4 2010 is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together.

Scope

- A snapshot of the global therapeutic scenario for Obesity.

- A review of the Obesity products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Obesity pipeline on the basis of therapeutic class, route of administration and molecule type.

- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Obesity.

- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.

- Devise corrective measures for pipeline projects by understanding Obesity pipeline depth and focus of Obesity therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

For more information, please visit:

http://www.aarkstore.com/reports/Obesity-Pipeline-Review-Q4-2010-86505.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

POST COMMENT

A Solution To The Obesity Epidemic Obesity Cure Comes Easy With Hcg Weight Loss Tacoma Plan The Diet Solution Program Ebook-She has overcome her obesity problem Get Rid Of Obesity Effectively With Natural Treatments And Remedies What You Should Know About Obesity A Long Term Solution To The Problem Of Obesity -- Shed Weight Boot Camp Diet Pills Obesity Obesity in UAE and Arab Countries Obesity Treatment The Risk Of Obesity Getting rid of obesity using Generic Meridia EssayEmpire Offers Research Papers on Obesity CustomTermPapers Offers Research Papers on Obesity